Ultra-Processed Food Linked to IBD Risk

Ultra-Processed Food Linked to IBD Risk

Lead Paragraph

A large prospective study has found that people with higher intake of ultra-processed food face an increased risk of developing inflammatory bowel disease (IBD), a group of chronic conditions that includes Crohn’s disease and ulcerative colitis. Published in The BMJ, the findings add substantial weight to long-standing questions about whether modern dietary patterns contribute to the rising global incidence of IBD, offering clinicians and patients further context for dietary discussions.

Background Context

IBD incidence has been rising steadily worldwide, particularly in countries undergoing rapid economic development and corresponding shifts towards Western-style diets. Researchers have long suspected that highly processed foods, often characterised by additives, emulsifiers, and refined ingredients, may disrupt gut barrier function or the microbiome in ways that promote intestinal inflammation. Until now, much of the supporting evidence came from smaller studies or research focused on individual nutrients rather than overall dietary patterns. This study sought to address that gap by examining ultra-processed food consumption across a large, geographically diverse population followed over an extended period, allowing researchers to assess risk while accounting for other lifestyle and demographic factors.

Key Findings

The study followed participants for a median of almost ten years, according to the researchers, tracking dietary habits alongside new diagnoses of IBD. Those who reported higher consumption of ultra-processed items, including soft drinks, refined sweetened products, and processed meats, showed a greater likelihood of developing the condition compared with participants who consumed these foods less frequently. The association held across several categories of ultra-processed items, while minimally processed foods such as unprocessed meats, dairy, and starches were not linked to the same increased risk. The authors are careful to note that the study demonstrates an association rather than direct proof of cause and effect, and they stress that further research is needed to identify which specific ingredients, additives, or processing techniques might be driving the pattern. Even so, the scale of the cohort and the length of follow-up lend meaningful weight to the findings, strengthening the broader case that dietary quality may play a role in disease onset.

Clinical Relevance

For people living with IBD, and for the gastroenterologists, dietitians, and IBD nurses supporting them, this research reinforces the growing evidence base connecting dietary patterns to gastrointestinal inflammation. While the study does not identify specific foods or additives to avoid, it supports the broader principle that food quality may be a relevant factor alongside genetics, environment, and immune function in the development of IBD. Clinicians may find this evidence useful when discussing general dietary quality with patients, though the authors are clear that findings should not be interpreted as prescriptive dietary guidance. Further research is needed before specific recommendations can be drawn.

Reference

Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374:n1554. doi:10.1136/bmj.n1554.

This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.

About the Author

Team Vance

Team Vance is the editorial team at Vance Medical, the medical foods company behind this hub. Vance Medical has spent more than thirty years in gastrointestinal medicine, developing nutritional products under the same regulatory frameworks that govern prescription medicines. The Hub exists to make that ground accessible, to people living with Crohn's disease, ulcerative colitis, IBS and related conditions, and to the clinicians treating them. Articles are written and edited in-house, and clinical claims are referenced to published research, with each study linked to its DOI so you can read the source rather than take our word for it. We publish primarily for a UK audience. Nothing here replaces advice from your own GP, gastroenterologist or dietitian.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or healthcare team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 31 August 2026
×
×